News
![GSK’s Omjjara EU-cleared for splenomegaly in myelofibrosis](https://pharmaphorum.com/sites/default/files/styles/x_large/public/2023-11/New%20GSKH.jpg?itok=nh303NIS)
GSK’s Omjjara EU-cleared for splenomegaly in myelofibrosis
GSK’s $1.9 billion takeover of Sierra Oncology has delivered the first new product, with the EU approval of Omjjara for the treatment of enlarged spleen (splenomegaly) or